Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

NCT00694200 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Not reached the statistical hypothesis at the interim analysis

Conditions

Breast Cancer

Interventions

DRUG: Vinorelbine
DRUG: Bevacizumab

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]